From adipose tissue protein secretion to adipopharmacology of disease

F. Töre, A. B. Tonchev, M. Fiore, N. Tunçel, P. Atanassova, L. Aloe, G. N. Chaldakov

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

An extensive research in the last few years has identified about hundred adipose tissue-secreted proteins, named adipokines or adipocytokines. However, our knowledge of the structures and molecules involved in the intracellular secretory pathway (synthesis, translocation, folding, targeting, sorting, storage, and exocytosis) of adipokines is at present limited. Relatively more is known about insulin-responsive trafficking of glucose transporters (GLUTs). Adipokines have multiple biological functions beyond lipid and carbohydrate metabolism, whereas GLUT4 is the major glucose transporter of adipocytes and skeletal muscles. Adipokines play an important role in the pathogenesis of a wide variety of diseases, and dysregulation of GLUT4 transport is implicated in insulin resistance and related disorders. Conceptually, adipobiology of disease has emerged as a novel field of studies in basic and clinical medicine. Here we present a state-of-the-science on some aspects of these studies with a special reference to the intracellular secretory pathway, focusing on adiponectin, GLUT4, and nerve growth factor (NGF), and suggesting that each step of this pathway may be a potential drug target. Given the beneficial effects of adiponectin, NGF and GLUT4 on various metabolic, vascular and inflammatory processes, a hypothesis of metabotrophic factor deficit in the pathogenesis of adipose-linked diseases is discussed. Adipopharmacological evaluation of this hypothesis may provide novel targets for drug development.

Original languageEnglish
Pages (from-to)149-155
Number of pages7
JournalImmunology, Endocrine and Metabolic Agents in Medicinal Chemistry
Volume7
Issue number2
DOIs
Publication statusPublished - Apr 2007

Fingerprint

Adipokines
Adipose Tissue
Secretory Pathway
Adiponectin
Nerve Growth Factor
Proteins
Glucose Transporter Type 4
Facilitative Glucose Transport Proteins
Clinical Medicine
Exocytosis
Carbohydrate Metabolism
Lipid Metabolism
Adipocytes
Pharmaceutical Preparations
Blood Vessels
Insulin Resistance
Skeletal Muscle
Research

Keywords

  • Adipobiology
  • Adiponectin
  • Drugs
  • Endoplasmic reticulum
  • GLUT4
  • Metabotrophic factors
  • Microtubules
  • NGF

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Pharmacology

Cite this

Töre, F., Tonchev, A. B., Fiore, M., Tunçel, N., Atanassova, P., Aloe, L., & Chaldakov, G. N. (2007). From adipose tissue protein secretion to adipopharmacology of disease. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, 7(2), 149-155. https://doi.org/10.2174/187152207780363712

From adipose tissue protein secretion to adipopharmacology of disease. / Töre, F.; Tonchev, A. B.; Fiore, M.; Tunçel, N.; Atanassova, P.; Aloe, L.; Chaldakov, G. N.

In: Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Vol. 7, No. 2, 04.2007, p. 149-155.

Research output: Contribution to journalArticle

Töre, F, Tonchev, AB, Fiore, M, Tunçel, N, Atanassova, P, Aloe, L & Chaldakov, GN 2007, 'From adipose tissue protein secretion to adipopharmacology of disease', Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, vol. 7, no. 2, pp. 149-155. https://doi.org/10.2174/187152207780363712
Töre, F. ; Tonchev, A. B. ; Fiore, M. ; Tunçel, N. ; Atanassova, P. ; Aloe, L. ; Chaldakov, G. N. / From adipose tissue protein secretion to adipopharmacology of disease. In: Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry. 2007 ; Vol. 7, No. 2. pp. 149-155.
@article{88c5e6e5b6c64a8aaab15045b97d2ce3,
title = "From adipose tissue protein secretion to adipopharmacology of disease",
abstract = "An extensive research in the last few years has identified about hundred adipose tissue-secreted proteins, named adipokines or adipocytokines. However, our knowledge of the structures and molecules involved in the intracellular secretory pathway (synthesis, translocation, folding, targeting, sorting, storage, and exocytosis) of adipokines is at present limited. Relatively more is known about insulin-responsive trafficking of glucose transporters (GLUTs). Adipokines have multiple biological functions beyond lipid and carbohydrate metabolism, whereas GLUT4 is the major glucose transporter of adipocytes and skeletal muscles. Adipokines play an important role in the pathogenesis of a wide variety of diseases, and dysregulation of GLUT4 transport is implicated in insulin resistance and related disorders. Conceptually, adipobiology of disease has emerged as a novel field of studies in basic and clinical medicine. Here we present a state-of-the-science on some aspects of these studies with a special reference to the intracellular secretory pathway, focusing on adiponectin, GLUT4, and nerve growth factor (NGF), and suggesting that each step of this pathway may be a potential drug target. Given the beneficial effects of adiponectin, NGF and GLUT4 on various metabolic, vascular and inflammatory processes, a hypothesis of metabotrophic factor deficit in the pathogenesis of adipose-linked diseases is discussed. Adipopharmacological evaluation of this hypothesis may provide novel targets for drug development.",
keywords = "Adipobiology, Adiponectin, Drugs, Endoplasmic reticulum, GLUT4, Metabotrophic factors, Microtubules, NGF",
author = "F. T{\"o}re and Tonchev, {A. B.} and M. Fiore and N. Tun{\cc}el and P. Atanassova and L. Aloe and Chaldakov, {G. N.}",
year = "2007",
month = "4",
doi = "10.2174/187152207780363712",
language = "English",
volume = "7",
pages = "149--155",
journal = "Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents",
issn = "1871-5222",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - From adipose tissue protein secretion to adipopharmacology of disease

AU - Töre, F.

AU - Tonchev, A. B.

AU - Fiore, M.

AU - Tunçel, N.

AU - Atanassova, P.

AU - Aloe, L.

AU - Chaldakov, G. N.

PY - 2007/4

Y1 - 2007/4

N2 - An extensive research in the last few years has identified about hundred adipose tissue-secreted proteins, named adipokines or adipocytokines. However, our knowledge of the structures and molecules involved in the intracellular secretory pathway (synthesis, translocation, folding, targeting, sorting, storage, and exocytosis) of adipokines is at present limited. Relatively more is known about insulin-responsive trafficking of glucose transporters (GLUTs). Adipokines have multiple biological functions beyond lipid and carbohydrate metabolism, whereas GLUT4 is the major glucose transporter of adipocytes and skeletal muscles. Adipokines play an important role in the pathogenesis of a wide variety of diseases, and dysregulation of GLUT4 transport is implicated in insulin resistance and related disorders. Conceptually, adipobiology of disease has emerged as a novel field of studies in basic and clinical medicine. Here we present a state-of-the-science on some aspects of these studies with a special reference to the intracellular secretory pathway, focusing on adiponectin, GLUT4, and nerve growth factor (NGF), and suggesting that each step of this pathway may be a potential drug target. Given the beneficial effects of adiponectin, NGF and GLUT4 on various metabolic, vascular and inflammatory processes, a hypothesis of metabotrophic factor deficit in the pathogenesis of adipose-linked diseases is discussed. Adipopharmacological evaluation of this hypothesis may provide novel targets for drug development.

AB - An extensive research in the last few years has identified about hundred adipose tissue-secreted proteins, named adipokines or adipocytokines. However, our knowledge of the structures and molecules involved in the intracellular secretory pathway (synthesis, translocation, folding, targeting, sorting, storage, and exocytosis) of adipokines is at present limited. Relatively more is known about insulin-responsive trafficking of glucose transporters (GLUTs). Adipokines have multiple biological functions beyond lipid and carbohydrate metabolism, whereas GLUT4 is the major glucose transporter of adipocytes and skeletal muscles. Adipokines play an important role in the pathogenesis of a wide variety of diseases, and dysregulation of GLUT4 transport is implicated in insulin resistance and related disorders. Conceptually, adipobiology of disease has emerged as a novel field of studies in basic and clinical medicine. Here we present a state-of-the-science on some aspects of these studies with a special reference to the intracellular secretory pathway, focusing on adiponectin, GLUT4, and nerve growth factor (NGF), and suggesting that each step of this pathway may be a potential drug target. Given the beneficial effects of adiponectin, NGF and GLUT4 on various metabolic, vascular and inflammatory processes, a hypothesis of metabotrophic factor deficit in the pathogenesis of adipose-linked diseases is discussed. Adipopharmacological evaluation of this hypothesis may provide novel targets for drug development.

KW - Adipobiology

KW - Adiponectin

KW - Drugs

KW - Endoplasmic reticulum

KW - GLUT4

KW - Metabotrophic factors

KW - Microtubules

KW - NGF

UR - http://www.scopus.com/inward/record.url?scp=34247599387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247599387&partnerID=8YFLogxK

U2 - 10.2174/187152207780363712

DO - 10.2174/187152207780363712

M3 - Article

VL - 7

SP - 149

EP - 155

JO - Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents

JF - Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents

SN - 1871-5222

IS - 2

ER -